In the BioHarmony Drug Report Database

"Preview" Icon

Delavirdine

Rescriptor (delavirdine) is a small molecule pharmaceutical. Delavirdine was first approved as Rescriptor on 1997-04-04. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA.

 

Trade Name

 

Rescriptor
 

Common Name

 

delavirdine
 

ChEMBL ID

 

CHEMBL593
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Antivirals

Image (chem structure or protein)

Delavirdine structure rendering